In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 9, 1999, Pages 1020-1026

  Selznick, Lee A ^a   Holtzman, David M ^a   Han, Byung Hee ^a   Gökden, Murat ^a   Srinivasan, Anu N ^b   Johnson Jr , Eugene M ^a   Roth, Kevin A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

Alzheimer disease; Amyloid beta; Apoptosis; Autophagy; Caspase 3; Granulovacuolar degeneration

Indexed keywords

AMYLOID BETA PROTEIN; CASPASE 3;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; ENZYME ACTIVATION; ENZYME ANALYSIS; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LEARNING; MEMORY; MOUSE; NERVE CELL; NERVE CELL DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0032873466     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199909000-00012     Document Type: Article

References (42)

1. Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 1990;250:279-82
2. Watt JA, Pike CJ, Walencewicz-Wasserman AJ, Cotman CW. Ultrastructural analysis of β-amyloid-induced apoptosis in cultured hippocampal neurons. Brain Research 1994;661:147-56
3. Estus S, Tucker HM, van Rooyen C, et al. Aggregated amyloid-β protein induces cortical neuronal apoptosis and concomitant "apoptotic" pattern of gene induction. J Neuroscience 1997;17:7736-45
4. Mullan M, Crawford F, Axelman K, et al. A pathogenic mutation for probable Alzheimer's disease in the APP at the N-terminus of β-amyloid. Nature Genet 1992;1:345-47
5. Verbeek MM, Ruiter DJ, de Wall RMW. The role of amyloid in the pathogenesis of Alzheimer's disease. Biol Chem 1997;378:937-50
6. Vogel G. Tau protein mutations confirmed as neuron killers. Science 1998;280:1524-25
7. Johnson EM. Possible role of neuronal apoptosis in Alzheimer's disease. Neurobiol Aging 1994;15:S187-S189
8. Cotman CW. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease. Neurobiol Aging 1998;19:S29-S32
9. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57
10. Perry G, Nunomura A, Smith MA. A suicide note from Alzheimer's disease neurons? Nature Medicine 1998;4:897-98
11. Guo Q, Fu W, Xie J, et al. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Nature Medicine 1998;4:957-62
12. Kitamura Y, Shimohama S, Kamoshima W, et al. Alteration of proteins regulating apoptosis: bcl-2, bcl-x, bax, bak, bad, ICH-1 and CPP32 in Alzheimer's disease. Brain Research 1998;780:260-69
13. Desjardins P, Ledoux S. Expression of ced-3 and ced-9 homologs in Alzheimer's disease cerebral cortex. Neuroscience Letters 1998;244:69-72
14. Kuida K, Zheng TS, Na S, et al. Decreased apoptosis in the brain and premature lethality in cpp32-deficient mice. Nature 1996;384: 368-72
15. Srinivasan A, Roth KA, Sayers RO, et al. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell death and differentiation 1998;5:1004-16
16. Masliah E, Mallory M, Alford M, et al. Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease. J Neuropath Exp Neurol 1998;57:1041-52
17. Gervais FG, Xu D, Robertson GS, et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation. Cell 1999;97:395-406
18. Raff M. Cell suicide for beginners. Nature 1998;396:119-22
19. Namura S, Zhu JM, Fink K, et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neuroscience 1998;18:3659-68
20. Parsadanian AS, Cheng Y, Kellerpeck CR, Holtzman DM, Snider WD. BCL-X(L) is an antiapoptotic regulator for postnatal CNS neurons. J Neuroscience 1998;18:1009-19
21. Cheng Y, Deshmukh M, D'Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in rat model of neonatal hypoxic-ischemic brain injury. J Clin Investigation 1998;101: 1992-99
22. Holtzman DM, Kilbridge J, Li Y, et al. TrkA expression in the CNS: Evidence for the existence of several novel NGF-responsive neurons. J Neuroscience 1995;15:1567-76
23. Shindler KS, Yunker AMR, Cahn R, Zha JP, Korsmeyer SJ, Roth KA. Trophic support promotes survival of bcl-x-deficient telencephalic cells in vitro. Cell Death and Differentiation 1998;5:901-10
24. Tomlinson BE, Kitchener D. Granulovacuolar degeneration of hippocampal pyramidal cells. J Path 1972;106:165-85
25. Ball MJ, Lo P. Granulovacuolar degeneration in the ageing brain and in dementia, J Neuropathol Exp Neurol 1977;36:474-87
26. Esiri MM, et al. Aging and dementia. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology Vol. Six. London: Arnold, 1997: 153-233
27. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 1996;274:99-102
28. Stadelmann C, Bruck W, Bancher C, Jellinger K, Lassmann H. Alzheimer's disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol 1998;57:456-64
29. Smale G, Nichols NR, Brady DR, Finch CE, Horton Jr. WE. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995;133:225-30
30. Troncoso JC, Sukhov RR, Kawas CH, Koliatsos VE. In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: Correlations with senile plaques and disease progression. J Neuropathol Exp Neurol 1996;55:1134-42
31. Migheli A, Cavalla P, Marino S, Schiffer D. A study of apoptosis in normal and pathological nervous tissue after in situ end-labeling of DNA strand breaks. Neuropathol Exp Neurol 1994;53:606-16
32. McCarthy NJ, Evan GI. Methods for detecting and quantifying apoptosis. Current Topics in Devel Biol 1998;36:259-79
33. Michaelis ML, Ranciat N, Chen Y, et al. Protection against β-amyloid toxicity in primary neurons by paclitaxel (taxol). J Neurochem 1998;70:1623-27
34. Jordan J, Galindo MF, Miller RJ. Role of calpain- and interleukin-1β converting enzyme-like proteases in the β-amyloid-induced death of rat hippocampal neurons in culture. J Neurochem 1997;68: 1612-21
35. Paradis EP, Douillard H, Koutroumanis M, Goodyer C, LeBlanc A. Amyloid β peptide of Alzheimer's disease downregulates bcl-2 and upregulates bax expression in human neurons. J Neuroscience 1996;16:7533-39
36. Cotman CW, Pike CJ, Copani A. β-amyloid neurotoxicity: A discussion of in vitro findings. Neurobiol Aging 1992;13:587-90
37. Busciglio, J, Lorenzo A, Yankner BA. Methodological variables in the assessment of beta amyloid neurotoxicity 1992;13:609-12
38. Price DL, Borchelt DR, Walker LC, Sisodia SS. Toxicity of synthetic Aβ peptides and modeling of Alzheimer's disease. Neurobiol Aging 1992;13:623-25
39. Clarke PGH. Developmental cell death: Morphological diversity and multiple mechanisms. Anat Embryol 1990;181:195-213
40. Cataldo AM, Paskevich PA, Kominami E, Nixon RA. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci USA 1991;88:10998-1002
41. Cataldo AM, Barnett JL, Berman SA, et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system. Neuron 1995;14:671-80
42. Cataldo AM, Nixon RA. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci USA 1990;87:3861-65